Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00018343 |
Recruitment Status :
Completed
First Posted : July 5, 2001
Last Update Posted : January 21, 2009
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Alzheimer's Disease | Drug: estrogen | Phase 2 |
Study Type : | Interventional (Clinical Trial) |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double |
Primary Purpose: | Treatment |
Official Title: | Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen |
Study Start Date : | April 1998 |
Study Completion Date : | March 2001 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 50 Years to 90 Years (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
- Post menopausal women with alzheimer's disease
- free of any major medical or neurological disease,
- medically safe to be treated with estrogen.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00018343
United States, Washington | |
VA Puget Sound Health Care System | |
Lakewood, Washington, United States, 98493-5000 |
OverallOfficial: | Suzanne Craft, Ph.D | ||
OverallOfficial: | Laura Baker, Ph.D | ||
OverallOfficial: | Murray Raskind, M.D. |
ClinicalTrials.gov Identifier: | NCT00018343 |
Other Study ID Numbers: |
AGCG-007-97F |
First Posted: | July 5, 2001 Key Record Dates |
Last Update Posted: | January 21, 2009 |
Last Verified: | December 2004 |
Alzheimer Disease Dementia Brain Diseases Central Nervous System Diseases Nervous System Diseases Tauopathies Neurodegenerative Diseases |
Neurocognitive Disorders Mental Disorders Estrogens Hormones Hormones, Hormone Substitutes, and Hormone Antagonists Physiological Effects of Drugs |